Literature DB >> 25205860

Reliability of the mouse model of choroidal neovascularization induced by laser photocoagulation.

Stephen H Poor1, Yubin Qiu1, Elizabeth S Fassbender1, Siyuan Shen1, Amber Woolfenden1, Andrea Delpero1, Yong Kim1, Natasha Buchanan1, Thomas C Gebuhr1, Shawn M Hanks1, Erik L Meredith1, Bruce D Jaffee1, Thaddeus P Dryja1.   

Abstract

PURPOSE: We attempted to reproduce published studies that evaluated whether the following factors influence choroidal neovascularization (CNV) induced by laser photocoagulation in murine retinas: small interfering RNA (siRNA), cobra venom factor, complement factors C3 and C5, and complement receptor C5aR. In addition, we explored whether laser-induced CNV in mice was influenced by the vendor of origin of the animals.
METHODS: Reagents or genotypes reported by others to influence CNV in this model were assessed using our standard procedures. Retrospective analyses of control or placebo mice in many experiments were done to evaluate whether the CNV area induced by laser photocoagulation varied according to vendor.
RESULTS: Administration of the following agents did not have a substantial impact on the CNV induced by laser burns in mice: siRNA, low-molecular-weight inhibitor of the C5a receptor (PMX53), or cobra venom factor. Jackson Laboratory (JAX) mice lacking either C3 or C5 had increased neovascularization compared to non-littermate JAX wild-type controls. Taconic mice lacking C3 had reduced CNV compared to non-littermate Taconic wild-type control mice. A retrospective analysis of vehicle-treated wild-type C57BL/6 mice used as controls across 132 experiments conducted from 2007 to 2010 revealed that mice purchased from JAX or from Charles River produced less neovascularization than mice from Taconic.
CONCLUSIONS: We present our recommended methods for conducting experiments with the mouse laser-induced CNV model to enhance reproducibility and minimize investigator bias. Copyright 2014 The Association for Research in Vision and Ophthalmology, Inc.

Entities:  

Keywords:  VEGF; choroidal neovascularization; laser; mice

Mesh:

Substances:

Year:  2014        PMID: 25205860     DOI: 10.1167/iovs.14-15067

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  36 in total

Review 1.  Animal models of ocular angiogenesis: from development to pathologies.

Authors:  Chi-Hsiu Liu; Zhongxiao Wang; Ye Sun; Jing Chen
Journal:  FASEB J       Date:  2017-07-24       Impact factor: 5.191

2.  Ref-1/APE1 Inhibition with Novel Small Molecules Blocks Ocular Neovascularization.

Authors:  Sheik Pran Babu Sardar Pasha; Kamakshi Sishtla; Rania S Sulaiman; Bomina Park; Trupti Shetty; Fenil Shah; Melissa L Fishel; James H Wikel; Mark R Kelley; Timothy W Corson
Journal:  J Pharmacol Exp Ther       Date:  2018-08-03       Impact factor: 4.030

3.  Pathogenic role and therapeutic potential of pleiotrophin in mouse models of ocular vascular disease.

Authors:  Weiwen Wang; Michelle E LeBlanc; Xiuping Chen; Ping Chen; Yanli Ji; Megan Brewer; Hong Tian; Samantha R Spring; Keith A Webster; Wei Li
Journal:  Angiogenesis       Date:  2017-04-26       Impact factor: 9.596

4.  Inhibition of the alternative complement pathway accelerates repair processes in the murine model of choroidal neovascularization.

Authors:  Nathaniel Parsons; Balasubramaniam Annamalai; Elisabeth Obert; Gloriane Schnabolk; Stephen Tomlinson; Bärbel Rohrer
Journal:  Mol Immunol       Date:  2019-02-12       Impact factor: 4.407

Review 5.  Consensus guidelines for the use and interpretation of angiogenesis assays.

Authors:  Patrycja Nowak-Sliwinska; Kari Alitalo; Elizabeth Allen; Andrey Anisimov; Alfred C Aplin; Robert Auerbach; Hellmut G Augustin; David O Bates; Judy R van Beijnum; R Hugh F Bender; Gabriele Bergers; Andreas Bikfalvi; Joyce Bischoff; Barbara C Böck; Peter C Brooks; Federico Bussolino; Bertan Cakir; Peter Carmeliet; Daniel Castranova; Anca M Cimpean; Ondine Cleaver; George Coukos; George E Davis; Michele De Palma; Anna Dimberg; Ruud P M Dings; Valentin Djonov; Andrew C Dudley; Neil P Dufton; Sarah-Maria Fendt; Napoleone Ferrara; Marcus Fruttiger; Dai Fukumura; Bart Ghesquière; Yan Gong; Robert J Griffin; Adrian L Harris; Christopher C W Hughes; Nan W Hultgren; M Luisa Iruela-Arispe; Melita Irving; Rakesh K Jain; Raghu Kalluri; Joanna Kalucka; Robert S Kerbel; Jan Kitajewski; Ingeborg Klaassen; Hynda K Kleinmann; Pieter Koolwijk; Elisabeth Kuczynski; Brenda R Kwak; Koen Marien; Juan M Melero-Martin; Lance L Munn; Roberto F Nicosia; Agnes Noel; Jussi Nurro; Anna-Karin Olsson; Tatiana V Petrova; Kristian Pietras; Roberto Pili; Jeffrey W Pollard; Mark J Post; Paul H A Quax; Gabriel A Rabinovich; Marius Raica; Anna M Randi; Domenico Ribatti; Curzio Ruegg; Reinier O Schlingemann; Stefan Schulte-Merker; Lois E H Smith; Jonathan W Song; Steven A Stacker; Jimmy Stalin; Amber N Stratman; Maureen Van de Velde; Victor W M van Hinsbergh; Peter B Vermeulen; Johannes Waltenberger; Brant M Weinstein; Hong Xin; Bahar Yetkin-Arik; Seppo Yla-Herttuala; Mervin C Yoder; Arjan W Griffioen
Journal:  Angiogenesis       Date:  2018-08       Impact factor: 9.596

6.  Comprehensive analysis of mouse retinal mononuclear phagocytes.

Authors:  Anika Lückoff; Rebecca Scholz; Florian Sennlaub; Heping Xu; Thomas Langmann
Journal:  Nat Protoc       Date:  2017-05-04       Impact factor: 13.491

Review 7.  Complement factor H in AMD: Bridging genetic associations and pathobiology.

Authors:  Christopher B Toomey; Lincoln V Johnson; Catherine Bowes Rickman
Journal:  Prog Retin Eye Res       Date:  2017-09-18       Impact factor: 21.198

8.  A Mouse Model for Laser-induced Choroidal Neovascularization.

Authors:  Ronil S Shah; Brian T Soetikno; Michelle Lajko; Amani A Fawzi
Journal:  J Vis Exp       Date:  2015-12-27       Impact factor: 1.355

Review 9.  Retinal Vasculature in Development and Diseases.

Authors:  Ye Sun; Lois E H Smith
Journal:  Annu Rev Vis Sci       Date:  2018-09-15       Impact factor: 6.422

10.  Treatment of Experimental Choroidal Neovascularization via RUNX1 Inhibition.

Authors:  Lucia Gonzalez-Buendia; Santiago Delgado-Tirado; Miranda An; Michael O'Hare; Dhanesh Amarnani; Hannah A B Whitmore; Guannan Zhao; Jose M Ruiz-Moreno; Joseph F Arboleda-Velasquez; Leo A Kim
Journal:  Am J Pathol       Date:  2020-12-17       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.